These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2556189)

  • 21. Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration.
    Roy A; Everett D; Pickar D; Paul SM
    Arch Gen Psychiatry; 1987 Apr; 44(4):320-7. PubMed ID: 2436589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between 3H-imipramine binding, 14C-serotonin uptake, and the surface area of blood platelets.
    Demet EM; Chicz-Demet A; Shaffer E; Ocariz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):289-96. PubMed ID: 2163060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors.
    Tang SW; Cheung S; Strijewski A; Chudzik J; Helmeste D
    Psychiatry Res; 1990 Nov; 34(2):205-12. PubMed ID: 1962863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3H-imipramine binding to freshly prepared platelet membranes in depression.
    Theodorou AE; Katona CL; Davies SL; Hale AS; Kerry SM; Horton RW; Kelly JS; Paykel ES
    Psychiatry Res; 1989 Jul; 29(1):87-103. PubMed ID: 2549556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects.
    Halbreich U; Rojansky N; Zander KJ; Barkai A
    J Psychiatr Res; 1991; 25(1-2):7-18. PubMed ID: 1851224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personality features and platelet 3H-imipramine binding.
    Castrogiovanni P; Maremmani I; Di Muro A; Rotondo A; Marazziti D
    Neuropsychobiology; 1992; 25(1):11-3. PubMed ID: 1318512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.
    DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S
    Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
    Severson JA; Schneider LS; Fredrickson ER
    Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet [3H]-imipramine binding is not modified in Alzheimer's disease.
    Galzin AM; Davous P; Roudier M; Lamour Y; Poirier MF; Langer SZ
    Psychiatry Res; 1989 Jun; 28(3):289-94. PubMed ID: 2548223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased platelet 3H-imipramine binding in Parkinson's disease.
    Schneider LS; Chui HC; Severson JA; Sloane RB
    Biol Psychiatry; 1988 Jul; 24(3):348-51. PubMed ID: 2840980
    [No Abstract]   [Full Text] [Related]  

  • 38. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
    Friedl W; Propping P; Weck B
    Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.
    DeMet EM; Bell KM; Reist C; Gerner RH; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):315-29. PubMed ID: 1963694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.